In this article, we will take a look at the 10 Set-It-and-Forget-It Stocks to Buy Right Now.
A peace pact agreed upon by the United States and Iran on June 18 helped ease concerns about inflation that had been weighing on markets. The two sides declared a temporary agreement to maintain the ceasefire and reopen the Strait of Hormuz. The rebound occurred despite the Federal Reserve’s shift to a more hawkish stance, as inflation remained high and the labor market remained stable throughout the dispute with Iran.
Labor Department data on June 18 showed initial unemployment claims were a bit higher than expected but had cooled over the prior week. In contrast to their March estimates, nine Fed members now anticipate at least one rate hike before the year ends. Additionally, markets noted that Chair Kevin Warsh’s initial policy statement focused on achieving “price stability” but made no mention of maximum employment.
In response to Warsh’s remarks, SignatureFD Chief Investment Officer Tony Welch told Reuters that “markets got spooked by Warsh yesterday essentially promising to contain inflation.” That said, he added that the data remains supportive regardless of the Fed becoming increasingly hawkish.
Our Methodology
To identify the 10 set-it-and-forget-it stocks to buy, we screened for large-cap stocks (market cap above $10 billion) with a positive EPS over the past five years and an ROE of more than 15%. These stocks are also popular among analysts and elite hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 599.2% since May 2014, beating its benchmark by 372 percentage points (see more details here).
10. Deere & Company (NYSE:DE)
Deere & Company (NYSE:DE) ranks among the best set-it-and-forget-it stocks to buy right now. On May 26, RBC Capital increased its price target for Deere & Company (NYSE:DE) to $752 from $736, retaining an Outperform rating on the company’s shares. The firm referenced Deere’s second-quarter earnings, which outperformed forecasts despite the absence of an IEEPA tariff return.
Deere & Company (NYSE:DE) earned $6.55 per share, above the estimates of $5.70, while revenue came in at $13.37 billion, exceeding the expected $11.56 billion.
RBC highlighted that Deere’s fiscal 2026 outlook remained steady, given that the tariff return advantage was offset by a number of factors, including a downturn in South America. According to the firm, Deere continues to perform effectively in a hard climate.
Meanwhile, Freedom Broker increased its price target for Deere & Company (NYSE:DE) to $590 from $570 with a Hold rating. According to the firm, 2026 marks the low point of the major agricultural equipment cycle. Freedom also emphasized that Deere’s diverse portfolio is producing stronger intrinsic profitability at the cycle’s low stage when compared to past cycles.
Deere & Company (NYSE:DE) is an American company that manufactures agricultural, heavy, and forestry machinery, diesel engines, heavy-equipment drivetrains, and lawn-care equipment. The company also provides financial services and engages in other business operations.
9. Intuitive Surgical, Inc. (NASDAQ:ISRG)
Intuitive Surgical, Inc. (NASDAQ:ISRG) ranks among the best set-it-and-forget-it stocks to buy right now. On June 2, Piper Sandler restated its Overweight rating and $580 target on Intuitive Surgical, Inc. (NASDAQ:ISRG). The firm’s recent field check with the head of robotics at a prominent U.S. healthcare institution confirmed the firm’s positive opinion of the company. The hospital system has significant expertise with Intuitive Surgical’s da Vinci system, notably the DV5 model, as well as other robotic solutions.
The field check focused on issues regarding the long-term viability of US volume growth, third-party equipment reprocessing, and increasing competition.
Piper Sandler recognized many growth catalysts for Intuitive Surgical, Inc. (NASDAQ:ISRG), such as the ambulatory surgery center possibility, DV5 cardiovascular treatments, and My Intuitive+. The firm claimed it is convinced the basic fundamentals of the company remain solid and that prevailing concerns are blown out of proportion.
In addition, Intuitive Surgical, Inc. (NASDAQ:ISRG) recently announced upgrades to its da Vinci 5 robotic surgical system, which include improved Intuitive Telepresence and longer tool use, which is expected to be ready in June, subject to regulatory clearance.
Intuitive Surgical, Inc. (NASDAQ:ISRG) engages in the development, manufacturing, and marketing of da Vinci surgical systems and the Ion endoluminal system.
Hedge Fund Resource Center